Compare ACADIA Pharmaceuticals Inc. (ACAD) vs Iron Mountain Inc (IRM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ACADIA Pharmaceuticals Inc. vs Iron Mountain Inc — how do they compare? ACADIA Pharmaceuticals Inc. trades at $29.52 (market cap $5.07B), while Iron Mountain Inc trades at $122.41 (market cap $36.44B). The key difference: Iron Mountain Inc is far larger — about 7.2× ACADIA Pharmaceuticals Inc.'s market cap, and Iron Mountain Inc pays a 2.82% dividend while ACADIA Pharmaceuticals Inc. pays none. Which is the better fit depends on your goals.
| ACAD | IRM | |
|---|---|---|
Market Cap | $5.07B | $36.44B |
Sector | Health | Real Estate |
52-Week High | $29.41 | $133.06 |
52-Week Low | $20.06 | $78.86 |
Enterprise Value | $4.19B | $55.85B |
Dividend Yield | — | 2.82% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ACADIA Pharmaceuticals Inc.
Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
Read more on ACAD →About Iron Mountain Inc
Iron Mountain Inc is a record management services provider. The firm is organized as a REIT. Most of its revenue comes from its storage business, with the rest coming from value-added services. The firm primarily caters to enterprise clients in developed markets. Its business segments include Global RIM Business
Read more on IRM →
